Education
About Us
Working with TipRanks
Follow Us
Next Science Ltd (AU:NXS)
ASX:NXS
NXS Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.06 - AU$0.31
Previous CloseN/A
Volume90.61K
Average Volume (3M)764.45K
Market Cap
AU$40.97M
Enterprise ValueAU$26.59M
Total Cash (Recent Filing)AU$1.67M
Total Debt (Recent Filing)$2.49M
Price to Earnings (P/E)―
Beta1.42
Next Earnings
Aug 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding292,625,370
10 Day Avg. Volume315,437
30 Day Avg. Volume764,453
Financial Highlights & Ratios
PEG Ratio-0.10
Price to Book (P/B)7.43
Price to Sales (P/S)0.00
P/FCF Ratio-3.21
Enterprise Value/Market Cap0.65
Enterprise Value/Revenue0.45
Enterprise Value/Gross Profit1.44
Enterprise Value/Ebitda-6.45
Forecast
1Y Price Target
AU$0.41Price Target Upside189.49% Upside
Rating ConsensusModerate Sell
Number of Analyst Covering0
Next Science Ltd News
PremiumCompany Announcements
Next Science Ltd Updates Director’s Shareholding
PremiumCompany Announcements
Next Science Ltd Issues Shares to CEO as Part of Compensation Package
PremiumCompany Announcements
Next Science Limited Announces Successful 2025 AGM Results
PremiumCompany Announcements
Next Science Reports Operational Milestones and Strategic Growth in 2024
PremiumCompany Announcements
Next Science’s Derivative Complaint Dismissed Amid Ongoing Litigation
PremiumCompany Announcements
Next Science Ltd Announces Cessation of Securities
PremiumCompany Announcements
Next Science Reports Q1 FY25 Sales Decline Amid FDA Compliance EffortsPremiumCompany Announcements
Next Science Limited Updates Corporate Governance StatementOptions Prices
Currently, No data available
---
Ownership Overview
0.23% Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
99.77% Public Companies and
Individual Investors
NXS FAQ
What was Next Science Ltd’s price range in the past 12 months?
Next Science Ltd lowest share price was AU$0.06 and its highest was AU$0.30 in the past 12 months.
What is Next Science Ltd’s market cap?
Next Science Ltd’s market cap is AU$40.97M.
When is Next Science Ltd’s upcoming earnings report date?
Next Science Ltd’s upcoming earnings report date is Aug 27, 2025 which is in 37 days.
How were Next Science Ltd’s earnings last quarter?
Next Science Ltd released its earnings results on Feb 27, 2025. The company reported -AU$0.025 earnings per share for the quarter, beating the consensus estimate of -AU$0.029 by AU$0.004.
Is Next Science Ltd overvalued?
According to Wall Street analysts Next Science Ltd’s price is currently Undervalued.
Does Next Science Ltd pay dividends?
Next Science Ltd does not currently pay dividends.
What is Next Science Ltd’s EPS estimate?
Next Science Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Next Science Ltd have?
Next Science Ltd has 292,625,370 shares outstanding.
What happened to Next Science Ltd’s price movement after its last earnings report?
Next Science Ltd reported an EPS of -AU$0.025 in its last earnings report, beating expectations of -AU$0.029. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Next Science Ltd?
Currently, no hedge funds are holding shares in AU:NXS
Next Science Ltd Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
AU$0.41 (189.49% Upside)
AU$0.41 (189.49% Upside)
Blogger Sentiment
Bullish
AU:NXS Sentiment 70%
Sector Average 72%
Sector Average 72%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-78.57%
12-Months-Change
Fundamentals
Return on Equity
-130.18%
Trailing 12-Months
Asset Growth
-48.53%
Trailing 12-Months
Company Description
Next Science Ltd
Next Science Ltd (NXS) is a medical technology company focused on the development and commercialization of innovative solutions for the treatment of biofilm-based infections. Operating within the healthcare sector, the company's proprietary technology targets the protective biofilm matrix that shields bacteria, thus enhancing the effectiveness of antibiotics and reducing the recurrence of infections. Next Science's core products include wound care solutions, surgical washes, and sinus rinses, all designed to address a wide range of bacterial infections across various medical fields.
Technical Analysis
Medical Developments International Limited
―
Althea Group Holdings Ltd.
―
IDT Australia Limited
―
Cronos Australia Ltd.
―